KRS 304.17A-257: Coverage under health benefit plan for colorectal cancer

examinations and laboratory tests.

(1) A health benefit plan shall provide coverage for all colorectal cancer examinations

and laboratory tests specified in the most recent ve rsion of the American Cancer

Society guidelines for individuals referenced in paragraph (b)1. of this subsection

and the most recent version of the United States Multi -Society Task Force on

Colorectal Cancer guidelines for individuals referenced in paragra ph (b)2. of this

subsection for complete colorectal cancer screening of asymptomatic individuals as

follows:

(a) Coverage or benefits shall:

1. Include coverage for all United States Food and Drug Administration -

approved bowel preparation prescribed in con nection with a colorectal

cancer examination or laboratory test; and

2. Be provided for all colorectal cancer examinations and laboratory tests

administered at a frequency identified in the relevant guidelines; and

(b) The covered individual shall be:

1. Forty-five (45) years of age or older; or

2. Less than forty -five (45) years of age and at high risk for colorectal

cancer.

(2) (a) Except as provided in paragraph (b) of this subsection, the coverage required

by this section shall not be subject to:

1. Prior authorization; or

2. A deductible, coinsurance, or any other cost -sharing requirements for

services received from participating providers under the health benefit

plan.

(b) If the application of any requirement of paragraph (a)2. of this subsection

would be the sole cause of a health benefit plan's failure to qualify as a Health

Savings Account-qualified High Deductible Health Plan under 26 U.S.C. sec.

223, as amended, then the requirement shall not apply to that health benefit

plan until the minimum deductible under 26 U.S.C. sec. 223, as amended, is

satisfied.

(3) This section shall not be construed to limit coverage required by KRS 304.17A -259

or any other law.